Literature DB >> 2826817

Identification of the human papillomavirus E2 protein in genital tract tissues.

C C Li1, R V Gilden, S D Showalter, K V Shah.   

Abstract

A 27-kilodalton protein representing approximately 60% of the E2 open reading frame of human papillomavirus type 6 (HPV-6) was synthesized in a bacterial expression system. Affinity-purified polyclonal antibody to this protein detected the probable E2 gene product as a 50-kilodalton protein in most condylomas by Western blot (immunoblot) analysis. The E2-positive condylomas were associated with HPV-6, HPV-11, HPV-16, or unidentified HPVs.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2826817      PMCID： PMC250575          DOI： 10.1128/JVI.62.2.606-609.1988

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix.

Authors:  M M Pater; A Pater
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

2.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.

Authors:  C C Baker; W C Phelps; V Lindgren; M J Braun; M A Gonda; P M Howley
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

3.  Antibodies to a synthetic oligopeptide that react with herpes simplex virus type 1 and 2 glycoprotein C.

Authors:  M Zweig; S D Showalter; D J Simms; B Hampar
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

4.  Transcription of episomal papillomavirus DNA in human condylomata acuminata and Buschke-Löwenstein tumours.

Authors:  H Lehn; T M Ernst; G Sauer
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

5.  Functions of purified E1A protein microinjected into mammalian cells.

Authors:  B Krippl; B Ferguson; M Rosenberg; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene.

Authors:  A Seth; G F Vande Woude
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

Authors:  C Yee; I Krishnan-Hewlett; C C Baker; R Schlegel; P M Howley
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

8.  Identification of the human papilloma virus-1a E4 gene products.

Authors:  J Doorbar; D Campbell; R J Grand; P H Gallimore
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

9.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

Authors:  A Schneider-Gädicke; E Schwarz
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  DNA sequence and genome organization of genital human papillomavirus type 6b.

Authors:  E Schwarz; M Dürst; C Demankowski; O Lattermann; R Zech; E Wolfsperger; S Suhai; H zur Hausen
Journal:  EMBO J       Date:  1983       Impact factor: 11.598
View more
  4 in total

1.  E2 of cottontail rabbit papillomavirus is a nuclear phosphoprotein translated from an mRNA encoding multiple open reading frames.

Authors:  M S Barbosa; F O Wettstein
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Bovine papilloma virus-transformed cells contain multiple E2 proteins.

Authors:  N L Hubbert; J T Schiller; D R Lowy; E J Androphy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia.

Authors:  J Dillner; L Dillner; J Robb; J Willems; I Jones; W Lancaster; R Smith; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.

Authors:  M Lehtinen; A Leminen; J Paavonen; P Lehtovirta; H Hyöty; E Vesterinen; J Dillner
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.